These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8021821)

  • 1. Human T-cell lymphotropic virus type I disease in Argentine intravenous drug users with human immunodeficiency virus type 1 infection.
    Zala C; Zapiola I; Bouzas MB; Benetucci J; Lopez L; Gallo D; Hanson C; Muchinik GR
    J Acquir Immune Defic Syndr (1988); 1994 Aug; 7(8):870-1. PubMed ID: 8021821
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of human T cell lymphotrophic virus (HTLV) type I and II DNA in French anti-HTLV-I/II-negative intravenous drug users.
    Lefrère F; Wattel E; Mariotti M; Agis F; Gordien E; Lefrère JJ
    J Infect Dis; 1992 Jul; 166(1):212-3. PubMed ID: 1607702
    [No Abstract]   [Full Text] [Related]  

  • 3. Presence of human T-cell lymphotropic virus types I and II and coinfection with human immunodeficiency virus in different groups at risk in Argentina.
    Pampuro SE; Rabinovich RD; Martinez Peralta L; Gallo D; Hanson C; Libonatti O
    J Acquir Immune Defic Syndr (1988); 1993 Jul; 6(7):851-2. PubMed ID: 8509987
    [No Abstract]   [Full Text] [Related]  

  • 4. Low prevalence of HTLV-I/II infection among HIV-1-infected injecting drug users in Russia.
    Bobkova MR; Detkova NV; Buravtsova EV; Bondarenko VO; Bobkov AF; Pokrovsky VV; Taylor GP
    J Acquir Immune Defic Syndr; 1999 Aug; 21(4):354. PubMed ID: 10428120
    [No Abstract]   [Full Text] [Related]  

  • 5. Human immunodeficiency virus type 1 and other viral co-infections among young heterosexual men and women in Argentina.
    de los Angeles Pando M; Biglione MM; Toscano MF; Rey JA; Russell KL; Negrete M; Gianni S; Martinez-Peralta L; Salomon H; Sosa-Estani S; Montano SM; Olson JG; Sanchez JL; Carr JK; Avila MM
    Am J Trop Med Hyg; 2004 Aug; 71(2):153-9. PubMed ID: 15306703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
    Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T
    N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-1/2 among high-risk groups in Argentina: molecular diagnosis and prevalence of different sexual transmitted infections.
    Berini CA; Pando MA; Bautista CT; Eirin ME; Martinez-Peralta L; Weissenbacher M; Avila MM; Biglione MM
    J Med Virol; 2007 Dec; 79(12):1914-20. PubMed ID: 17935172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit.
    Ognjan AF; Lewandowski CA; Belian BT; Burczak J; Markowitz N; Lee H; Saravolatz LD
    Henry Ford Hosp Med J; 1992; 40(1-2):131-5. PubMed ID: 1428966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T lymphotropic virus type II (HTLV-II) infection in a cohort of New York intravenous drug users: an old infection?
    Khabbaz RF; Hartel D; Lairmore M; Horsburgh CR; Schoenbaum EE; Roberts B; Hartley TM; Friedland G
    J Infect Dis; 1991 Feb; 163(2):252-6. PubMed ID: 1988509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV infections among Swedish intravenous drug users in 1992.
    Andersson S; Krook A; Käll K; Julander I; Thorstensson R; Biberfeld G
    Scand J Infect Dis; 1995; 27(6):547-50. PubMed ID: 8685631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users.
    Schwebke J; Calsyn D; Shriver K; Saxon A; Kleyn J; Oluoch-Mitchell E; Olmstead L; Fisher LD; Krone M; Ashley R
    J Infect Dis; 1994 May; 169(5):962-7. PubMed ID: 8169427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell lymphotrophic virus in California's injection drug users.
    Trachtenberg AI; Gaudino JA; Hanson CV
    J Psychoactive Drugs; 1991; 23(2):225-32. PubMed ID: 1765894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence, risk factors and genetic characterization of human T-cell lymphotropic virus types 1 and 2 in patients infected with human immunodeficiency virus type 1 in the cities of Ribeirão Preto and São Paulo].
    Kleine Neto W; Sanabani SS; Jamal LF; Sabino EC
    Rev Soc Bras Med Trop; 2009; 42(3):264-70. PubMed ID: 19684973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.
    van den Hoek JA; Al EJ; Huisman JG; Goudsmit J; Coutinho RA
    J Med Virol; 1991 Jun; 34(2):100-3. PubMed ID: 1890409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overt and latent HIV 1 and HTLV-I infection in cohorts of at high risk individuals in Argentina.
    Lombardi V; Carrillo MG; Alimandi M; Boxaca M; Rossi P; Libonatti O
    Mol Cell Probes; 1991 Dec; 5(6):409-17. PubMed ID: 1779979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human T-lymphotropic Virus Co-infections in Adults Infected With Human Immunodeficiency Virus.
    Rossheim AE; Cunningham TD; Troy SB
    Am J Med Sci; 2016 Sep; 352(3):258-60. PubMed ID: 27650229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection with human T lymphotropic virus types I and II in sexually transmitted disease clinics in Baltimore and New Orleans.
    Wiktor SZ; Cannon RO; Atkinson WL; Lutz B; Hook EW; Blattner WA; Quinn TC
    J Infect Dis; 1992 May; 165(5):920-4. PubMed ID: 1569344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II.
    Hisada M; Chatterjee N; Zhang M; Battjes RJ; Goedert JJ
    J Infect Dis; 2003 Sep; 188(6):891-7. PubMed ID: 12964121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No proof of HTLV-I/II in intravenous drug abusers with a high rate of HIV-1 infection in central Thailand.
    Saguanwongse S; Muangpom A; Ruchusatsawat N; Wongcheree S; Warachit P; Miyamura K; Yamazaki S; Honda M
    Microbiol Immunol; 1996; 40(9):639-44. PubMed ID: 8908608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.